Register to leave comments

  • News bot March 9, 2026, 11:20 p.m.

    🔍 Desai Antal Rohit (Executive)

    Company: PROCEPT BioRobotics Corp (PRCT)

    Report Date: 2026-03-05

    Transaction Summary:

    • Total transactions: 9
    • Derivative instruments: 0
    • Holdings reported: 2
    • Total shares acquired: 426,262
    • Total shares held: 49,515

    Detailed Transactions and Holdings:

    • Acquired 142,498 shares of Common Stock at $25.4391 per share (Direct)
      Date: 2026-03-05 | Code: P | equity_swap_involved: 0 | shares_owned_after: 142,498.00 | transaction_form_type: 4 | Footnotes: F1, F2
    • Acquired 24,748 shares of Common Stock at $26.4073 per share (Direct)
      Date: 2026-03-05 | Code: P | equity_swap_involved: 0 | shares_owned_after: 167,246.00 | transaction_form_type: 4 | Footnotes: F3, F2
    • Acquired 106,554 shares of Common Stock at $23.3282 per share (Direct)
      Date: 2026-03-06 | Code: P | equity_swap_involved: 0 | shares_owned_after: 273,800.00 | transaction_form_type: 4 | Footnotes: F4, F2
    • Acquired 53,763 shares of Common Stock at $24.1019 per share (Direct)
      Date: 2026-03-06 | Code: P | equity_swap_involved: 0 | shares_owned_after: 327,563.00 | transaction_form_type: 4 | Footnotes: F5, F2
    • Acquired 43,581 shares of Common Stock at $24.0816 per share (Direct)
      Date: 2026-03-09 | Code: P | equity_swap_involved: 0 | shares_owned_after: 371,144.00 | transaction_form_type: 4 | Footnotes: F6, F2
    • Acquired 53,818 shares of Common Stock at $24.9052 per share (Direct)
      Date: 2026-03-09 | Code: P | equity_swap_involved: 0 | shares_owned_after: 424,962.00 | transaction_form_type: 4 | Footnotes: F7, F2
    • Acquired 1,300 shares of Common Stock at $25.4173 per share (Direct)
      Date: 2026-03-09 | Code: P | equity_swap_involved: 0 | shares_owned_after: 426,262.00 | transaction_form_type: 4 | Footnotes: F8, F2
    • Holds 0 shares of Common Stock (Direct)
      Date: 2026-03-05 | Code: H | shares_owned_after: 35,152.00
    • Holds 0 shares of Common Stock (Direct)
      Date: 2026-03-05 | Code: H | nature_of_ownership: By The 2:22 DNA Trust | shares_owned_after: 14,363.00

    Footnotes:

    • F1: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $25.0645 to $26.0213, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
    • F2: CPMG, Inc. is the general partner and investment manager of Kestrel Fund, L.P. Antal Desai, a member of the Issuer's board of directors and a shareholder and managing partner of CPMG, Inc., may be deemed to share voting and investment power with respect to the shares beneficially owned by Kestrel Fund, L.P. Mr. Desai disclaims beneficial ownership of the shares beneficially owned by Kestrel Fund, L.P. except to the extent of any pecuniary interest therein.
    • F3: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $26.10 to $26.98, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
    • F4: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $22.785 to $23.75, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
    • F5: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $23.79 to $24.50, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
    • F6: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $23.40 to $24.39, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
    • F7: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $24.40 to $25.39, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
    • F8: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $25.40 to $25.44, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.